Leishmania infantum: Lack of Parasite Resistance to Amphotericin B in a Clinically Resistant Visceral Leishmaniasis

Amphotericin B (AmB) has been used as a second-line treatment of visceral leishmaniasis, particularly in human immunodeficiency virus-positive patients. AmB median effective doses (ED(50)s) were determined on an isolate obtained before any treatment and on a second isolate obtained 4 years later fro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Durand, Remy, Paul, Muriel, Pratlong, Francine, Rivollet, Daniele, Dubreuil-Lemaire, Marie-Laure, Houin, Rene, Astier, Alain, Deniau, Michele
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1998
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC105889/
https://ncbi.nlm.nih.gov/pubmed/9687425
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados